Sumitomo Pharma Co., Ltd.'s Net Worth

-$590 Million

Estimate Recalculated Jul 1, 2024 08:02PM EST

Who is Sumitomo Pharma Co., Ltd.?

Sumitomo Pharma Co., Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Roivant Sciences Ltd., and Urovant Sciences Ltd..

SEC CIK

Sumitomo Pharma Co., Ltd.'s CIK is 0001446601

Past Insider Trading and Trends

2020 was Sumitomo Pharma Co., Ltd.'s most active year for acquiring shares with 51 total transactions. Sumitomo Pharma Co., Ltd.'s most active month to acquire stocks was the month of August. 2023 was Sumitomo Pharma Co., Ltd.'s most active year for disposing of shares, totalling 2 transactions. Sumitomo Pharma Co., Ltd.'s most active month to dispose stocks was the month of February. 2023 saw Sumitomo Pharma Co., Ltd. paying a total of $1,393,178,400.00 for 51,599,201 shares, this is the most they've acquired in one year. In 2023 Sumitomo Pharma Co., Ltd. cashed out on 19,359,282 shares for a total of $129,999,982.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Myovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
51.6M
$27.00
$1,393,178,400.00
45.8M
Mar 10
Form 4
-8.48%
-4.24M
—
—
45.8M
Mar 3
Form 4
+0.04%
20.68K
$22.85
$472,382.61
50.04M
Scheduled
Sep 28
Form 4
+0.17%
84K
$23.87
$2,004,937.44
50.02M
Scheduled
Sep 24 - Sep 27
Form 4
+0.28%
138.8K
$22.39
$3,108,225.66
49.94M
Scheduled
Sep 22 - Sep 23
Form 4
+0.16%
81.27K
$22.30
$1,812,119.53
49.8M
Scheduled
Sep 20 - Sep 21
Form 4
+0.18%
87.91K
$22.20
$1,951,655.51
49.72M
Scheduled
Sep 16 - Sep 17
Form 4
+0.33%
161.16K
$22.03
$3,551,175.01
49.63M
Scheduled
Sep 14 - Sep 15
Form 4
+0.23%
113.18K
$23.84
$2,698,438.60
49.47M
Scheduled
Sep 10 - Sep 13
Form 4
+0.12%
58.9K
$25.60
$1,507,810.80
49.35M
Scheduled
Sep 8 - Sep 9
Form 4
+0.13%
64.4K
$26.49
$1,705,922.61
49.3M
Scheduled
Sep 3 - Sep 7
Form 4
+0.21%
103.1K
$25.60
$2,638,920.66
49.23M
Scheduled
Sep 1 - Sep 2
Form 4
+0.22%
109K
$24.05
$2,620,983.90
49.13M
Scheduled
Aug 30 - Aug 31
Form 4
+0.16%
77.04K
$22.91
$1,765,163.94
49.02M
Scheduled
Aug 26 - Aug 27
Form 4
+0.13%
63.01K
$22.40
$1,411,426.82
48.94M
Scheduled
Aug 24 - Aug 25
Form 4
+0.21%
101.92K
$21.65
$2,206,276.42
48.88M
Scheduled
Aug 20 - Aug 23
Form 4
+0.13%
63.91K
$21.49
$1,373,513.04
48.78M
Scheduled
Aug 18 - Aug 19
Form 4
+0.15%
71.72K
$21.21
$1,521,194.21
48.71M
Scheduled
Aug 16 - Aug 17
Form 4
+0.18%
87.9K
$12.31
$1,081,911.74
48.64M
Scheduled
May 19 - May 20
Form 4
+0.17%
84.81K
$12.22
$1,036,590.02
48.55M
Scheduled
May 15 - May 18
Form 4
+0.19%
91.33K
$12.18
$1,112,400.58
48.47M
Scheduled
May 13 - May 14
Form 4
+0.12%
59.45K
$13.08
$777,788.94
48.38M
Scheduled
May 11 - May 12
Form 4/A
+0.10%
50K
$12.24
$612,075.00
48.25M
Scheduled
May 6
Form 4
+0.15%
70K
$12.73
$891,212.00
48.32M
Scheduled
May 7 - May 8
Form 4
+0.21%
100K
$11.97
$1,196,540.00
48.25M
Scheduled
May 5
Form 4
+0.21%
100K
$11.44
$1,144,050.00
48.15M
Scheduled
May 1 - May 4
Form 4
+0.21%
100K
$12.00
$1,199,720.00
48.05M
Scheduled
Apr 29 - Apr 30
Form 4
+0.19%
90.5K
$12.11
$1,096,022.24
47.95M
Scheduled
Apr 27 - Apr 28
Form 4
+0.16%
78.09K
$12.24
$955,447.10
47.86M
Scheduled
Apr 23 - Apr 24
Form 4
+0.21%
100.2K
$11.76
$1,177,870.30
47.78M
Scheduled
Apr 21 - Apr 22
Form 4
+0.25%
120.3K
$11.20
$1,347,961.28
47.68M
Scheduled
Apr 17 - Apr 20
Form 4
+0.30%
140K
$10.56
$1,478,372.00
47.56M
Scheduled
Apr 15 - Apr 16
Form 4
+0.30%
140K
$10.40
$1,456,651.00
47.42M
Scheduled
Apr 13 - Apr 14
Form 4
+0.15%
70K
$9.37
$655,669.00
47.28M
Scheduled
Apr 9
Form 4
+0.30%
140K
$8.37
$1,171,303.00
47.21M
Scheduled
Apr 7 - Apr 8
Form 4
+0.30%
140K
$8.18
$1,145,445.00
47.07M
Scheduled
Apr 3 - Apr 6
Form 4
+0.30%
140K
$7.60
$1,063,384.00
46.93M
Scheduled
Apr 1 - Apr 2
Form 4
+0.30%
140K
$7.81
$1,093,750.00
46.79M
Scheduled
Mar 30 - Mar 31
Form 4
+0.30%
140K
$7.96
$1,114,057.00
46.65M
Scheduled
Mar 26 - Mar 27
Form 4
+0.69%
319.3K
$7.65
$2,442,453.83
46.51M
Scheduled
Mar 24 - Mar 25
Form 4
+0.88%
405.1K
$7.64
$3,094,640.80
46.19M
Scheduled
Mar 20 - Mar 23
Form 4
+0.85%
387.8K
$7.54
$2,923,895.66
45.78M
Scheduled
Mar 18 - Mar 19
Form 4
+0.86%
387.8K
$7.32
$2,839,956.35
45.4M
Scheduled
Mar 16 - Mar 17
Form 3
—
0
—
—
0
No matching records found

Roivant Sciences Ltd. (ROIV) Snapshot price: $10.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.50%
-15.12M
$8.60
-$129,999,982.20
71.25M
Jun 22
Form 3
—
0
—
—
0
No matching records found

Urovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.45%
103.25K
$13.08
$1,350,510.00
22.96M
Feb 19
Form 3
—
0
—
—
0
No matching records found